drugset / Trial / NCT00435968

Safety and Immune Enhancing Effects of Acute Dosing of COLD-fX in Healthy Adults

NCT00435968 ↗

Phase 2 Completed 50 enrolled CV Technologies
RandomizedParallel-groupDouble-blindTreatment

Summary

Subjects will be asked to participate in a four day research study of the immune system effects and safety of short-term acute dosing of Cold-fX. The purpose of the study is to determine the effects of acute dosing of Cold-fX for 3 days on the immune system compared to a placebo (dummy pill). Safety of the acute dosing will be determined through various blood tests carried out during the study.

Timeline

Start
2007-03
Primary completion
—
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject CVT-E002 Other / unclassified 200 mg —

Indications

No indication recorded.